Features | Partner Sites | Information | LinkXpress
Sign In
KOREA E & EX
Schiller
RG Advertising

Midsized Uretroscope Takes Care of Smaller Anatomy

By HospiMedica International staff writers
Posted on 11 Jul 2013
Image: The Richard Wolf U-Care panoview uretroscope (Photo courtesy of Richard Wolf).
Image: The Richard Wolf U-Care panoview uretroscope (Photo courtesy of Richard Wolf).
A new endourology solution addresses smaller anatomies in cystoscopic and resection procedures, without compromising optical qualities.

The Richard Wolf U-Care line of rigid instrument is intended for treating adolescent patients that have outgrown pediatric instruments, but remain too small for standard ones. The slim 2.7 mm diameter extended length panoview endoscope instruments ensure complete examination, with optimal flow dynamics that provide a consistently clear field of view and flat-field, distortion-free images. The system also offers a wide variety of smaller instrumentation that enables atraumatic treatment solutions and fewer complications.

The U-Care line includes urethrotomes, cystoscopes, and resectoscopes, and is available in slender 4.25 or 4.75 mm outer sheaths with a 190 mm working length, thin enough to enable optimum treatment for patients who have smaller anatomy, but with a longer reach than standard pediatric-sized instruments. Instrumentation options include foreign body forceps, biopsy forceps, scissors, a passive cutting action working element, coagulation, cutting, and hook electrodes, and various shaped stricture scalpels. The U-Care line of products is manufactured by Richard Wolf Medical Instruments Corporation (RWMIC; Vernon Hills, IL, USA).

“Typically, physicians have to choose between instrumentation that may be too large or too small for the patients they are treating. With this product, we are providing urologists the right size tools to perform these procedures for every patient,” said Monica Sanders, corporate director of marketing for RWMIC. “The benefits of right-sizing to the patient make the U-Care line a critical breakthrough in patient comfort and physician care.”

“In a time where there is an increasing incidence of stone disease in the pediatric population, the need for finer and smaller caliber scopes has never been greater,” said Anand Palagiri, MD, director of pediatric urology at Mercy Clinic (St. Louis, MO, USA). “The craftsmanship, durability, and quality of the Richard Wolf pediatric endoscopic line has made treating pediatric stone disease easy, safe, and extremely successful.”

Related Links:

Richard Wolf Medical Instruments Corporation



Channels

Surgical Techniques

view channel

Raman Scattering Helps Evaluate Laser Ablation

Raman spectroscopy can be used to differentiate squamous cell carcinoma (SCC) from normal skin following treatment with high-powered lasers, according to a new study. Researchers at Florida Atlantic University (FAU; Boca Raton, USA) obtained 25 tissue samples from 11 patients undergoing Mohs micrographic surgery for... Read more

Women's Health

view channel

Nitrous Oxide for Labor Makes US Comeback

Long used for its anxiolytic properties during labor in European countries and Canada, nitrous oxide (N2O) use is resurging in the United States. While in countries such as Norway, New Zealand, Sweden, Australia, and England, usage rates of inhalational N2O during parturition reach 70%, it has only recently become an... Read more

Health IT

view channel
Image: Remote Intelligent Telehealth Assistant (RITA) (Photo courtesy of PR Newswire).

Telehealth Robot Launched to Increase Productivity of Doctors in Clinics and Hospitals

A robot uses high-definition monitors, high-speed components, and wireless communications, and serves as a telehealth media center to give doctors more flexibility in treating and assisting patients remotely.... Read more

Business

view channel

Pfizer to Buy Hospira to Bolster Hospital Products

Pfizer (New York, NY, USA) has entered into a definitive merger agreement with Hospira (Lake Forest, IL, USA), in a move designed to significantly enhance their global established pharmaceutical (GEP) business, for a total enterprise value of approximately USD 17 billion. The strategic complementary combination will... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.